Integrated biomarker profiling of the metabolome associated with impaired fasting glucose and type 2 diabetes mellitus in large‐scale Chinese patients-Reference-Cited by-同舟云学术

Integrated biomarker profiling of the metabolome associated with impaired fasting glucose and type 2 diabetes mellitus in large‐scale Chinese patients

Published:2021-06 Issue:6 Volume:11 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Long Jianglan¹²³,Yang Hui⁴,Yang Zhirui¹³,Jia Qingquan⁵,Liu Liwei⁵,Kong Lingwei⁶,Cui Huijing⁶,Ding Suying⁵,Qin Qian⁵,Zhang Nana⁷,Feng Xingzhong⁸,Yan Shuxun⁹,Tang Jinfa⁹,Chen Shuo¹⁰,Han Yumei¹⁰,Jiang Tao³,Wen Zhen³,Qi Ningning³,Deng Kejun⁴,Sun Zhi⁵,Lin Hao⁴,Yan Dan¹²^ORCID

Affiliation:

1. Beijing Friendship Hospital, Capital Medical University Beijing China

2. Beijing Key Laboratory for Evaluation of Rational Drug Use Beijing China

3. Beijing Shijitan Hospital, Capital Medical University Beijing China

4. College of Life Science and Technology University of Electronic Science and Technology of China Chengdu Sichuan China

5. The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan China

6. Beijing Jiaotong University Community Health Center Beijing China

7. Department of Pharmacy Kaifeng Hospital of Traditional Chinese Medicine Kaifeng Henan China

8. Department of Endocrinology and Immunology Yuquan Hospital of Tsinghua University Beijing China

9. Department of Endocrinology The First Affiliated Hospital of Henan University of CM Zhengzhou Henan China

10. Beijing Physical Examination Center Beijing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.432

Reference10 articles.

1. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment;Danaei G;Lancet Diabetes Endocrinol,2014

2. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study

3. A Large‐scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma

4. Metabolic signatures and risk of type 2 diabetes in a Chinese population: an untargeted metabolomics study using both LC-MS and GC-MS

5. Novel biomarkers for pre‐diabetes identified by metabolomics

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of LC–MS/MS in clinical laboratories;Clinica Chimica Acta;2024-03

2. A bi-layer model for identification of piwiRNA using deep neural learning;Journal of Biomolecular Structure and Dynamics;2023-08-22

3. Integrated biomarker profiling of the metabolome associated with type 2 diabetes mellitus among Tibetan in China;Diabetology & Metabolic Syndrome;2023-07-01

4. i2OM: Toward a better prediction of 2′-O-methylation in human RNA;International Journal of Biological Macromolecules;2023-06

5. A random forest-based metabolic risk model to assess the prognosis and metabolism-related drug targets in ovarian cancer;Computers in Biology and Medicine;2023-02